Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2005

Feb 28, 2005

30339_dirs_2005-02-28_d8c238f2-9c96-4716-9975-6cede9e1d8a5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2005-02-25

Reporting Person: HUGILL HERBERT L (Pres.of the Americas, Pharma.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2005-02-25 Common stocks A 12.1818 $25.8500 Acquired 4846.8433 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common stocks 21638.0438 Direct

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.